Table 3. Comparison of EGFR T790M detection platforms in plasma.
S.No | Method | Sample | EGFR T790M detection rate % | Study Group | |
---|---|---|---|---|---|
Treatment Naive/Pre-TKI | Post-TKI | ||||
1 | BEAMing | Plasma N = 44 | 4.8 | 43.5 | Taniguchi et al. [106] |
2 | Scorpion ARMS | Plasma N = 26 | 34.8 | 64 | Maheswaran et al. [109] |
3 | ARMS | Plasma N = 135 | 5.8 | 31.1 | Wang Z et al. [89] |
Digital PCR | 25.2 | 43.0 | |||
4 | Mutant-enriched PCR | Plasma N = 33 | NA | 36.4 | He et al. [74] |
Direct Sequencing | NA | 6.1 | |||
5 | Cobas (Roche) | Plasma N = 23 | 0 | 39 | Sorensen et al. [99] |
6 | ddPCR | Plasma N = 49 | - | 28.6 | Lee et al. [104] |
7 | SABER | Plasma N = 75 | - | 28 | Sakai et al. [120] |
8 | ddPCR | Plasma N = 12 | - | 41.7 | Isobe K et al. [92] |
9 | Mutation-biased PCR | Plasma N = 58 | - | 40 | Sueoka-Aragane N et al. [112] |
10 | Mutation-biased PCR | Plasma N = 19 | - | 53 | Nakamura T et al. [78] |
PNA-LNA PCR | - | 15.7 | |||
Cycleave PCR | - | 26.3 | |||
ASO-PCR | - | 31.5 | |||
Direct sequencing | - | 31.5 | |||
11 | Cobas (Roche) | Plasma N = 15 | 0 | 33.3 | Marchetti A et al. [100] |
NGS (Roche) | 0 | 33.3 | |||
12 | Cobas (Roche) | Plasma N = 238 | 0.8 | 2.01 | Mok T et al. [88] |
13 | NGS (Illumina) Hi Seq |
Plasma N = 45 | - | 42.2 | Jin Y et al. [114] |
14 | NGS (MiSeq) | Plasma N = 15 | - | 60 | Paweletz et al. [95] |
15 | Ion Torrent PGM NGS | Plasma N = 190 | 16.8 | Uchida J et al. [121] |
‘-‘ :Not reported.